At a glance
- Originator Bayer; Meiji Seika Kaisha
- Developer Meiji Seika Kaisha
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Helminthiasis
Most Recent Events
- 16 Sep 1999 Preclinical development for Helminthiasis in Japan (Intraperitoneal)